Stock Yards Bank & Trust Co. Has $2 Million Holdings in Colgate-Palmolive (NYSE:CL)

Stock Yards Bank & Trust Co. decreased its position in Colgate-Palmolive (NYSE:CL) by 10.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,029 shares of the company’s stock after selling 2,856 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Colgate-Palmolive were worth $1,995,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. GUNN & Co INVESTMENT MANAGEMENT INC. bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $1,636,000. Commerzbank Aktiengesellschaft FI bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $375,000. Cetera Trust Company N.A acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $80,000. Hussman Strategic Advisors Inc. lifted its position in Colgate-Palmolive by 25.0% during the fourth quarter. Hussman Strategic Advisors Inc. now owns 21,000 shares of the company’s stock worth $1,674,000 after acquiring an additional 4,200 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its holdings in Colgate-Palmolive by 1.3% during the 4th quarter. Handelsbanken Fonder AB now owns 414,836 shares of the company’s stock worth $33,067,000 after purchasing an additional 5,498 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 1.4 %

NYSE:CL opened at $88.33 on Tuesday. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The firm’s fifty day moving average is $87.19 and its 200-day moving average is $81.06. The firm has a market cap of $72.61 billion, a P/E ratio of 31.77, a P/E/G ratio of 3.27 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the prior year, the firm posted $0.77 earnings per share. The business’s quarterly revenue was up 6.9% compared to the same quarter last year. Equities analysts expect that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a $0.50 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s payout ratio is presently 71.94%.

Insider Buying and Selling at Colgate-Palmolive

In other news, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Gregory Malcolm sold 8,930 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the sale, the executive vice president now directly owns 8,043 shares of the company’s stock, valued at approximately $686,470.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director C Martin Harris sold 2,760 shares of the stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. 0.37% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of analyst reports. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Monday, January 29th. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. Evercore ISI boosted their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a report on Thursday, January 18th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.